2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

• Published in: Canadian journal of cardiology Vol. 32; no. 10; pp. 1170 - 1185
• Main Authors: Macle, Laurent, MD, Cairns, John, MD, Leblanc, Kori, PharmD, Tsang, Teresa, MD, Skanes, Allan, MD, Cox, Jafna L., MD, Healey, Jeff S., MD, Bell, Alan, MD, Pilote, Louise, MD, Andrade, Jason G., MD, Mitchell, L. Brent, MD, Atzema, Clare, MD, Gladstone, David, MD, Sharma, Mike, MD, Verma, Subodh, MD, Connolly, Stuart, MD, Dorian, Paul, MD, Parkash, Ratika, MD, Talajic, Mario, MD, Nattel, Stanley, MD, Verma, Atul, MD
• Format: Journal Article
• Language: English
• Published: England Elsevier Inc 01.10.2016
• Subjects: Acute Coronary Syndrome - therapy; Algorithms; Anticoagulants - therapeutic use; Atrial Appendage - surgery; Atrial Fibrillation - complications; Atrial Fibrillation - therapy; Cardiac Pacing, Artificial; Cardiotonic Agents - administration & dosage; Cardiotonic Agents - adverse effects; Cardiovascular; Catheter Ablation; Coronary Artery Disease - complications; Digoxin - administration & dosage; Digoxin - adverse effects; Drug Therapy, Combination; Factor Xa Inhibitors - therapeutic use; Fibrinolytic Agents - therapeutic use; Hemorrhage - chemically induced; Hemorrhage - prevention & control; Humans; Magnesium - therapeutic use; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors - therapeutic use; Postoperative Complications - prevention & control; ST Elevation Myocardial Infarction - therapy; Stroke - prevention & control
• ISSN: 0828-282X; 1916-7075
• DOI: 10.1016/j.cjca.2016.07.591

Abstract The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in AF management. This 2016 Focused Update deals with: (1) the management of antithrombotic therapy for AF patients in the context of the various clinical presentations of coronary artery disease; (2) real-life data with non-vitamin K antagonist oral anticoagulants; (3) the use of antidotes for the reversal of non-vitamin K antagonist oral anticoagulants; (4) digoxin as a rate control agent; (5) perioperative anticoagulation management; and (6) AF surgical therapy including the prevention and treatment of AF after cardiac surgery. The recommendations were developed with the same methodology used for the initial 2010 guidelines and the 2012 and 2014 Focused Updates. Using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) standards, individual studies and literature were reviewed for quality and bias; the literature review process and evidence tables are included in the Supplementary Material, and on the CCS Web site. The section on concomitant AF and coronary artery disease was developed in collaboration with the CCS Antiplatelet Guidelines Committee. Details of the updated recommendations are presented, along with their background and rationale. This document is linked to an updated summary of all CCS AF Guidelines recommendations, from 2010 to the present 2016 Focused Update.